ES2540327T3 - Derivados de 8-hidroxiquinolin-7-carboxamida terciaria y usos de los mismos - Google Patents

Derivados de 8-hidroxiquinolin-7-carboxamida terciaria y usos de los mismos Download PDF

Info

Publication number
ES2540327T3
ES2540327T3 ES10800763.4T ES10800763T ES2540327T3 ES 2540327 T3 ES2540327 T3 ES 2540327T3 ES 10800763 T ES10800763 T ES 10800763T ES 2540327 T3 ES2540327 T3 ES 2540327T3
Authority
ES
Spain
Prior art keywords
nitrogen
sulfur
oxygen
taken together
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10800763.4T
Other languages
English (en)
Spanish (es)
Inventor
Stefania Gagliardi
Simone Del Sordo
Federico Mailland
Michela Legora
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Polichem SA
Original Assignee
Polichem SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42026678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2540327(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem SA filed Critical Polichem SA
Application granted granted Critical
Publication of ES2540327T3 publication Critical patent/ES2540327T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/113Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES10800763.4T 2009-12-29 2010-12-28 Derivados de 8-hidroxiquinolin-7-carboxamida terciaria y usos de los mismos Active ES2540327T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09180902A EP2345643A1 (en) 2009-12-29 2009-12-29 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
EP09180902 2009-12-29
PCT/EP2010/070790 WO2011080264A1 (en) 2009-12-29 2010-12-28 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof

Publications (1)

Publication Number Publication Date
ES2540327T3 true ES2540327T3 (es) 2015-07-09

Family

ID=42026678

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10800763.4T Active ES2540327T3 (es) 2009-12-29 2010-12-28 Derivados de 8-hidroxiquinolin-7-carboxamida terciaria y usos de los mismos

Country Status (37)

Country Link
US (1) US8729098B2 (https=)
EP (2) EP2345643A1 (https=)
JP (1) JP5808754B2 (https=)
KR (1) KR101666505B1 (https=)
CN (2) CN105384685A (https=)
AU (1) AU2010338267B2 (https=)
BR (1) BR112012015728A2 (https=)
CA (1) CA2783213C (https=)
CL (1) CL2012001757A1 (https=)
CY (1) CY1116493T1 (https=)
DK (1) DK2519505T3 (https=)
DO (1) DOP2012000186A (https=)
EA (1) EA025563B1 (https=)
EC (1) ECSP12012007A (https=)
ES (1) ES2540327T3 (https=)
GE (1) GEP20156244B (https=)
GT (1) GT201200216A (https=)
HR (1) HRP20150749T1 (https=)
HU (1) HUE027220T2 (https=)
IL (1) IL220427A (https=)
MA (1) MA33829B1 (https=)
MX (1) MX2012007748A (https=)
MY (1) MY161869A (https=)
NI (1) NI201200114A (https=)
NZ (1) NZ600788A (https=)
PE (1) PE20130179A1 (https=)
PH (1) PH12012501326A1 (https=)
PL (1) PL2519505T3 (https=)
PT (1) PT2519505E (https=)
RS (1) RS54096B1 (https=)
SG (1) SG181586A1 (https=)
SI (1) SI2519505T1 (https=)
SM (1) SMT201500182B (https=)
TN (1) TN2012000320A1 (https=)
UA (1) UA107949C2 (https=)
WO (1) WO2011080264A1 (https=)
ZA (1) ZA201204347B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2345642A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
EP2345641A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. New secondary 8-hydroxyquinoline-7-carboxamide derivatives
JP6092261B2 (ja) * 2012-02-24 2017-03-08 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 抗ウイルス化合物
US9751838B2 (en) 2012-10-02 2017-09-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Tetrahydroquinoline derivatives and their use as Epac inhibitors
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EP4699762A3 (en) 2020-09-22 2026-04-22 Milwaukee Electric Tool Corporation Staple and staple collation
USD976093S1 (en) 2020-09-22 2023-01-24 Milwaukee Electric Tool Corporation Staple collation
EP4237201A4 (en) 2020-10-30 2024-12-11 Milwaukee Electric Tool Corporation POWERED FASTENER DRIVER

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US326328A (en) 1885-09-15 Broiler
US326330A (en) 1885-09-15 Harness-support
DE540842C (de) 1930-08-06 1931-12-28 Chinosol Fabrik Akt Ges Verfahren zur Darstellung der 8-Acetyloxychinolin-7-carbonsaeure
CA2215514A1 (en) 1995-04-08 1996-10-17 Basf Aktiengesellschaft Method of controlling harmful fungi
US6194413B1 (en) * 1995-11-13 2001-02-27 Smithkline Beecham Corporation Hemoregulatory compounds
US6310211B1 (en) 1996-09-10 2001-10-30 Pharmacia & Upjohn Company 8-hydroxy-7-substituted quinolines as anti-viral agents
KR20010015639A (ko) * 1997-09-30 2001-02-26 스즈키 다다시 술포닐 유도체
JP2001294572A (ja) * 2000-02-09 2001-10-23 Dai Ichi Seiyaku Co Ltd 新規スルホニル誘導体
EP1326611B1 (en) 2000-10-12 2007-06-13 Merck & Co., Inc. Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
PL360944A1 (en) 2000-10-12 2004-09-20 Merck & Co, Inc. Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
JP3616628B2 (ja) 2001-03-01 2005-02-02 塩野義製薬株式会社 Hivインテグラーゼ阻害活性を有する含窒素芳香族複素環化合物
ATE404537T1 (de) 2002-08-13 2008-08-15 Shionogi & Co Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung
WO2005033079A1 (ja) * 2003-09-30 2005-04-14 Eisai Co., Ltd. ヘテロ環化合物を含有する新規な抗真菌剤
FR2889192A1 (fr) * 2005-07-27 2007-02-02 Cytomics Systems Sa Composes antifongiques, compositions contenant ces composes et leurs utilisations
WO2008014307A2 (en) * 2006-07-26 2008-01-31 Novartis Ag Inhibitors of undecaprenyl pyrophosphate synthase
WO2009140215A2 (en) * 2008-05-11 2009-11-19 Geraghty, Erin Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds
EP2947082A1 (en) * 2009-11-10 2015-11-25 Pfizer Inc N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS
TW201130842A (en) * 2009-12-18 2011-09-16 Incyte Corp Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
EP2345642A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
EP2345641A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. New secondary 8-hydroxyquinoline-7-carboxamide derivatives

Also Published As

Publication number Publication date
PE20130179A1 (es) 2013-02-24
ZA201204347B (en) 2013-09-25
PL2519505T3 (pl) 2015-11-30
CN102686566A (zh) 2012-09-19
IL220427A (en) 2015-04-30
BR112012015728A2 (pt) 2019-09-24
HK1178526A1 (en) 2013-09-13
PH12012501326A1 (en) 2015-04-01
UA107949C2 (xx) 2015-03-10
DK2519505T3 (en) 2015-06-29
EA025563B1 (ru) 2017-01-30
SMT201500182B (it) 2015-09-07
JP5808754B2 (ja) 2015-11-10
KR20120101563A (ko) 2012-09-13
AU2010338267A2 (en) 2012-07-26
NI201200114A (es) 2013-04-22
CA2783213A1 (en) 2011-07-07
PT2519505E (pt) 2015-09-03
AU2010338267A1 (en) 2012-07-19
KR101666505B1 (ko) 2016-10-14
EP2519505A1 (en) 2012-11-07
HRP20150749T1 (hr) 2015-08-14
HUE027220T2 (hu) 2016-10-28
TN2012000320A1 (en) 2013-12-12
CY1116493T1 (el) 2017-03-15
EA201270670A1 (ru) 2013-03-29
CA2783213C (en) 2017-09-12
AU2010338267B2 (en) 2014-03-27
EP2345643A1 (en) 2011-07-20
SI2519505T1 (sl) 2015-08-31
EP2519505B1 (en) 2015-05-27
CL2012001757A1 (es) 2013-03-22
MX2012007748A (es) 2012-08-03
NZ600788A (en) 2013-08-30
WO2011080264A1 (en) 2011-07-07
ECSP12012007A (es) 2012-08-31
US20120309751A1 (en) 2012-12-06
DOP2012000186A (es) 2013-01-15
SG181586A1 (en) 2012-07-30
GEP20156244B (en) 2015-02-10
US8729098B2 (en) 2014-05-20
MY161869A (en) 2017-05-15
MA33829B1 (fr) 2012-12-03
JP2013515755A (ja) 2013-05-09
CN105384685A (zh) 2016-03-09
RS54096B1 (sr) 2015-10-30
GT201200216A (es) 2014-12-26

Similar Documents

Publication Publication Date Title
ES2540327T3 (es) Derivados de 8-hidroxiquinolin-7-carboxamida terciaria y usos de los mismos
UY30296A1 (es) Compuestos fenil amido heterociclicos condensados
AR112834A1 (es) Derivados de rapamicina
PE20160501A1 (es) Derivados de quinolizina sustituidos utiles como inhibidores de integrasa del vih
AR077695A1 (es) Derivados de pirimidina como inhibidores del factor ixa
UY30334A1 (es) Derivados de triazolopirazina
ECSP099269A (es) Compuestos de fenilurea como inhibidores de epóxido hidrolasa soluble
PE20151781A1 (es) Piridonamidas como moduladores de canales de sodio
AR079226A1 (es) Espiroindolinona- pirrolidinas, procesos de preparacion y uso de los mismos para el tratamiento y profilaxis del cancer
CO6300861A2 (es) Compuestos inhibidores de dipeptidil peptidasa iv metodos de preparacion de los mismos y composiciones farmaceuticas que los contienen como agentes activos
AR046297A1 (es) Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo
AR079205A1 (es) Morfolinotiazoles como moduladores alostericos positivos alfa 7
AR094876A1 (es) Derivados de ácido betulínico modificados con alquilo c-3 y alquenilo
EA201991349A1 (ru) Тетрациклические гетероциклические соединения, полезные в качестве ингибиторов интегразы вич
MX392270B (es) Oxisteroles sustituidos en c7 y metodos de uso de los mismos.
MY148482A (en) Heterocyclic compound and pharmaceutical composition thereof
AR094812A1 (es) Derivado de piridina monocíclico como inhibidor del fgfr
MX2018006390A (es) Composiciones y metodos para tratar accidente cerebrovascular isquemico.
MX2021011118A (es) Derivados de azolopiridina macrocíclicos como moduladores de eed y prc2.
BR112014012610A2 (pt) método para tratar infecção causada pelo vírus da hepatite c utilizando composições contendo quercetina
CO2019004978A2 (es) Compuestos terapéuticos y métodos para utilizarlos
AR089020A1 (es) Agentes de reversion anticoagulante
AR082111A1 (es) Furopiridinas o tienopiridinas condensadas, composiciones farmaceuticas que las contienen utiles para tratar trastornos psicoticos y del sistema nervioso central, y metodo de preparacion de las mismas
AR109735A1 (es) Método para la síntesis de derivado de 3-fenil-2,3,4,8,9,10-hexahidropirano[2,3-f]cromeno e isómero óptico del mismo
AR087470A1 (es) Derivados imidazolicos bifenilenicos y composiciones farmaceuticas que los contienen